| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/12/2000 | EP1017390A2 Combinations of hmg-coa inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP1017379A1 Therapeutic compositions |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259870A Fatty emulsing contg. reducing sugar and method for sterilizing same |
| 07/12/2000 | CN1259383A Capsule for lowering sugar of diabetes |
| 07/12/2000 | CN1259353A Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof |
| 07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087378 The active benzo(b)thiophene compounds for treating osteoporosis and cardiovascular disorders, especially hyperlipidemia |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087353 Comprising one or more esterified and subsequently hydrogenated phytosterols; enhanced solubility/dispersability, increased molar potency and enhanced stability over naturally isolated phytosterol |
| 07/11/2000 | US6087338 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 07/11/2000 | US6087334 Anti-diabetic peptides |
| 07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6086878 By administering a gastrointestinal neuromodulator antibody, such as antibodies to bombesin, cholecystokinin, gastrin, somatostatin, and neuropeptide y; for egg or milk-producing animals |
| 07/11/2000 | US6086789 Medical uses of pyruvates |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039331A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039249A1 Ume extract having medicinal effects and compositions containing the same |
| 07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039141A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 07/06/2000 | WO2000039140A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same |
| 07/06/2000 | WO2000039128A1 5ht1 antagonists for antidepressant therapy |
| 07/06/2000 | WO2000039123A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039122A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039120A2 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039113A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 07/06/2000 | WO2000039099A1 Benzimidazole derivatives |
| 07/06/2000 | WO2000039097A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | WO2000039090A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039083A2 Pyrazole compounds and uses thereof |
| 07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038729A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038728A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications |
| 07/06/2000 | WO2000038727A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038726A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
| 07/06/2000 | WO2000038725A1 Combinations for cardiovascular indications |
| 07/06/2000 | WO2000038724A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038723A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| 07/06/2000 | WO2000038721A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038703A1 Agent for treating visual cell function disorder |
| 07/06/2000 | WO2000038698A2 Substances from porcine tissue |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038675A1 Treatment of conditions with a need for the inhibition of gsk-3 |
| 07/06/2000 | WO2000038666A2 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000021910A3 1,2-disubstituted cyclopropanes |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO1999061600A9 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | CA2356885A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same |
| 07/06/2000 | CA2356838A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | CA2356692A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356664A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 07/06/2000 | CA2356607A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | CA2356515A1 Combinations for cardiovascular indications |
| 07/06/2000 | CA2356382A1 Agent for treating visual cell function disorder |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2356156A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2355097A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 07/06/2000 | CA2354053A1 A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016415A2 Use of a fibrin glue for the regeneration of tissue |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015451A1 Tetrahydro gamma-carbolines |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015007A1 Analogs of peptide yy and uses thereof |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015002A1 Metal compounds, mixed or sulphated, as phosphate binders |
| 07/05/2000 | EP1014997A1 Substance and method for reduction of lipids and cholesterol |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |